4//SEC Filing
SHALLCROSS STEVEN A 4
Accession 0001104659-23-006677
CIK 0000894158other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 6:03 AM ET
Size
5.6 KB
Accession
0001104659-23-006677
Insider Transaction Report
Form 4
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
- Purchase
Common Stock
2023-01-25$0.87/sh+25,000$21,825→ 160,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.860 through $0.875, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Theriva Biologics, Inc.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001263501
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 6:03 AM ET
- Size
- 5.6 KB